Dulaglutide generic?

Dulaglutide generic

- What it is:
Dulaglutide is a once‑weekly GLP‑1 (glucagon‑like peptide‑1) receptor agonist that helps lower blood sugar in type 2 diabetes. The drug’s generic name is simply dulaglutide—the same as the active ingredient in the brand‑name product.

- Brand name currently:
In the United States it is sold under the brand name Trulicity™, manufactured by Eli Lilly.

- Is a generic version available?
As of now (2026), the FDA has not approved a generic version of dulaglutide. That means you’ll still find it only as the branded Trulicity.

The “generic” would carry the same name (dulaglutide) and be identical in potency, purity, and dosage form once it receives approval. Generics for biologics like dulaglutide are usually called biosimilars and must prove that they are highly similar to the reference product in terms of safety, effectiveness, and manufacturing quality.

- When could a generic appear?
* Biosimilar development is ongoing, but timelines are uncertain.
* Approval depends on a sponsor submitting a biologics license application (BLA) that satisfies the FDA’s stringent similarity requirements.
* Once a biosimilar receives approval, it can be marketed at a lower price, potentially expanding access.

- How it’s used (in case you’re comparing):
* Dose – 0.75 mg or 1.5 mg once weekly (via pre‑filled pen).
* Route – subcutaneous injection.
* Indication – adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes.

- Alternatives:
If cost or insurance coverage is a concern, you might discuss other GLP‑1 agents with your clinician—e.g., semaglutide (Ozempic®, Rybelsus®), exenatide (Byetta®, Bydureon®), or tirzepatide (Mounjaro®). Some of these already have generic or biosimilar options in development.

---

Bottom line:
- Dulaglutide is the generic name.
- Currently, only the branded Trulicity is on the market.
- A generic/biosimilar version may become available in the future, but it’s not yet approved.

If you’re looking for cost‑effective options, talk to your healthcare provider or pharmacist about what’s covered under your insurance plan and whether a comparable GLP‑1 therapy might fit your needs.